WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Urticaria

Urticaria (hives) is a non-specific vascular response to a wide variety of stimuli. Commonly, acute urticaria has an allergic basis as a type I hypersensitivity state mediated by IgE. It can also be triggered by chemical and physical stimuli including cholinergic activity, sunlight, localized pressure, heat and cold. However, in more than 95% of patients, the exogenous cause can not be found. As many as 20% of persons probably experience the condition at some time in their lives. It is characterized by cutaneous wheals (erythematous, oedematous, pruritic papules) that blanch on pressure. Angio-oedema is a variant of urticaria that predominantly affects the mucous membranes. Most episodes of urticaria are transient and individual lesions may last for a few minutes to a few days, depending on the cause. The reaction can, however, become chronic and persist for many months.

Hereditary angio-oedema is a disease with an autosomal dominant trait. Large swellings may be triggered by trauma, including surgery. Since the lesions may involve the upper airways, there may be narrowing of the respiratory tract, a condition that requires emergency treatment. A hereditary angio-oedema-like syndrome sometimes occurs in patients with lymphoproliferative diseases, lymphosarcoma and chronic lymphocytic leukaemia.

Cholinergic urticaria is common in young adults after vigorous exercise or hot showers or under conditions of emotional stress. It can be accompanied by other signs of cholinergic activation including abdominal cramps, dizziness and wheezing. The lesions are usually confined to the trunk. Most regress within 30-60 minutes, but occasionally they are more persistent and coalesce.

Dermatographism is a very common form of urticaria. Wheals can be induced by scratching or rubbing of the skin and even by stimuli such as the beating of a hard shower stream.

Cold urticaria is characterized by localized pruritus, erythema and swelling which develop rapidly in response to a cold stimulus. Predisposed individuals risk shock, loss of consciousness and even death from drowning if they plunge into cold water.

Urticarial vasculitis, which is sometimes associated with systemic lupus erythematosus, has similar clinical features to urticaria but is a totally different condition resulting from a necrotizing vasculitis probably caused by the deposition of immune complexes. Because the wheals result from an inflammatory reaction, they tend to persist for a few days. Patients should be investigated for the presence of systemic lupus erythematosus.

Management

If there is obstruction of the airways, as in angio-oedema, this is considered a medical emergency and epinephrine, 1:1000 solution (0.5-1.0 ml), should be given intramuscularly. Occasionally dietary restriction is of value when the history is suggestive of food-induced urticaria. Acetylsalicylic acid and opioids should be avoided in patients with urticaria if they are suspected of being causative. While it is sometimes possible to relieve the underlying cause, in most cases reliance has to be placed on symptomatic treatment with antihistamines such as chlorphenamine and hydroxyzine. The new non-sedating antihistamines have the advantage of not interfering with daytime activities, but they are often not as effective for urticaria.

Selective desensitization, which may be directed to physical as well as chemical stimuli, is sometimes effective. For instance, frequent hot baths for patients with cholinergic urticaria and controlled graduated exposure to ultraviolet light for those with solar urticaria sometimes induce a useful measure of tolerance.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012